Fig. 6From: Exploring the effectiveness of molecular subtypes, biomarkers, and genetic variations as first-line treatment predictors in Asian breast cancer patients: a systematic review and meta-analysisPooled pCR outcome of NAC-treated Asian breast cancer patients according to biomarkers. Forest plots describing the random effect ORs and 95% CIs from studies assessing the association of pCR outcome in (A) NAC TA-treated breast cancer patients in biomarkers Ki-67; NAC TP-treated breast cancer patients in biomarkers (B) ER; (C) PR; (D) HR; and (E) Ki-67. I2 and p-value for X2 of heterogeneity are reported for each group analysisBack to article page